Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 30, 2025
[Effectiveness of Angiotensin System Inhibitors Against Painful Peripheral Neuropathy in Type 2 Diabetic Old Patients: Validation by Analysis of Pharmacy Claims Data]Takashi Yamamoto, Tomoyoshi Miyamoto, Shiori Iwane, et al.
Pain|March 10, 2007
Hydrogen sulfide as a novel nociceptive messengerAtsufumi Kawabata, Tsuyoshi Ishiki, Keita Nagasawa, et al.
Life Sciences|April 17, 2007
The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodentsHiroyasu Ishikura, Sachiyo Nishimura, Maho Matsunami, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 4, 2025
Thrombomodulin-Induced Prevention of Peripheral Neuropathy in Oxaliplatin-Treated Mice Involves Complement C5a Inactivation and PAR1 Activation in Addition To HMGB1 DegradationKengo Maruo, Maho Tsubota, Kazuki Tajima, et al.
British Journal of Pharmacology|March 8, 2006
Suppression of pancreatitis-related allodynia/hyperalgesia by proteinase-activated receptor-2 in miceAtsufumi Kawabata, Maho Matsunami, Masahiro Tsutsumi, et al.
Journal of Pharmacological Sciences|November 28, 2024
Involvement of Cav3.2 T-type Ca2+ channels and cystathionine-β-synthase in colitis-related visceral hypersensitivity in miceMaho Tsubota, Yuriko Iba, Tsukasa Hatakeyama, et al.
Life Sciences|October 12, 2010
The proteinase/proteinase-activated receptor-2/transient receptor potential vanilloid-1 cascade impacts pancreatic pain in miceSachiyo Nishimura, Hiroyasu Ishikura, Maho Matsunami, et al.
British Journal of Pharmacology|January 19, 2005
2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in miceAtsufumi Kawabata, Yuko Oono, Daiki Yonezawa, et al.
Journal of Pharmacological Sciences|April 16, 2021
Estrogen decline is a risk factor for paclitaxel-induced peripheral neuropathy: Clinical evidence supported by a preclinical studyTomoyoshi Miyamoto, Shiori Hiramoto, Ayano Kanto, et al.
Pageof 13